IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIMOLDI, ISABELLA SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.234
NA - Nord America 7.863
AS - Asia 6.739
SA - Sud America 756
AF - Africa 166
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.631
SG - Singapore 2.275
CN - Cina 2.256
GB - Regno Unito 2.160
IT - Italia 1.964
DE - Germania 985
SE - Svezia 826
BR - Brasile 578
HK - Hong Kong 549
RU - Federazione Russa 521
IN - India 518
IE - Irlanda 296
FR - Francia 280
NL - Olanda 232
KR - Corea 198
FI - Finlandia 179
JP - Giappone 170
DK - Danimarca 167
TR - Turchia 162
ID - Indonesia 160
CA - Canada 144
ES - Italia 137
VN - Vietnam 133
UA - Ucraina 118
CH - Svizzera 58
PL - Polonia 57
AT - Austria 54
CI - Costa d'Avorio 53
BE - Belgio 51
CO - Colombia 51
MX - Messico 49
IR - Iran 45
AR - Argentina 41
PK - Pakistan 41
EU - Europa 40
AU - Australia 39
TW - Taiwan 33
GR - Grecia 29
ZA - Sudafrica 29
BD - Bangladesh 28
CZ - Repubblica Ceca 26
CL - Cile 23
EC - Ecuador 22
IQ - Iraq 22
PH - Filippine 22
IL - Israele 19
RO - Romania 19
MA - Marocco 17
MY - Malesia 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
DZ - Algeria 14
EG - Egitto 14
VE - Venezuela 14
SC - Seychelles 13
PE - Perù 11
PT - Portogallo 11
TH - Thailandia 11
NZ - Nuova Zelanda 10
AL - Albania 9
AZ - Azerbaigian 9
CR - Costa Rica 9
NO - Norvegia 9
BG - Bulgaria 8
HU - Ungheria 8
JM - Giamaica 7
LT - Lituania 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
HR - Croazia 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
LV - Lettonia 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
BZ - Belize 3
CM - Camerun 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
MV - Maldive 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
IM - Isola di Man 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TZ - Tanzania 2
A1 - Anonimo 1
Totale 23.821
Salva come PNG Salva come JPEG
Città #
Southend 1.907
Singapore 1.234
Dallas 965
Ashburn 829
Milan 777
Chandler 563
Hong Kong 452
Beijing 424
Fairfield 416
Seattle 329
Wilmington 279
Dublin 264
Hefei 255
Ann Arbor 253
Council Bluffs 252
Princeton 241
Houston 225
Frankfurt am Main 224
Woodbridge 213
Los Angeles 189
Bengaluru 187
Cambridge 180
Santa Clara 171
Munich 167
Jakarta 121
Nanjing 114
Tokyo 86
Guangzhou 84
Phoenix 82
Boardman 81
Buffalo 81
Dearborn 81
Moscow 79
Des Moines 77
Toronto 77
Helsinki 75
Jacksonville 73
New York 73
Mountain View 63
Columbus 61
Redmond 59
Redwood City 58
Seoul 58
Medford 55
San Jose 54
Abidjan 53
São Paulo 53
Berlin 52
Bologna 48
Shanghai 48
Cangzhou 45
Padova 45
Brussels 43
Jinan 43
Andover 41
Istanbul 41
Bogotá 39
Hangzhou 39
Ho Chi Minh City 38
Nuremberg 38
Changsha 37
The Dalles 37
Kent 36
Shenyang 36
Kolkata 35
San Diego 34
Karlsruhe 33
Naples 33
Roxbury 33
Somerville 33
Florence 31
Rome 31
Serra 31
Sakarya 30
Nanchang 29
Zhengzhou 29
Hanoi 28
Chicago 27
London 27
Tianjin 27
Vienna 27
Bergamo 26
Boston 26
Fremont 26
Turku 26
Lappeenranta 25
Shenzhen 25
Wuhan 25
Rio de Janeiro 24
Saint Petersburg 24
Eitensheim 23
Fuzhou 23
Amsterdam 22
Warsaw 22
Mumbai 21
Athens 20
Bühl 20
Zaragoza 20
Central District 19
Orem 19
Totale 14.354
Salva come PNG Salva come JPEG
Nome #
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 383
Amphiphilic Pt(II) complexes for in vivo bioimaging applications 382
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 371
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media 328
1,4-bis-difosfino-(Z)-2-buteni, 1,4 disostituiti otticamente puri in qualità di leganti chirali per la catalisi omogenea stereocontrollata con metalli di transizione 317
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 271
Luminescent amphiphilic Pt(II) complexes and their assemblies 267
Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra 266
Self-assembly in vivo: imaging and reactivity 263
Sensitivity of mesenchymal stromal cells to a new imidazole-based cationic Pt(II) complex with high in vitro anticancer activity 259
Conventional and non-conventional catalytic systems for the asymmetric reduction of cyclic imines 259
Simple 1,3-diamines and their application as ligands in ruthenium(ii) catalysts for asymmetric transfer hydrogenation of aryl ketones 256
Ruthenium(II) complexes bearing (NNN) ligand : catalytic evaluation of different solvent-mediated coordination modes 250
Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity 249
Cascade Reaction by Chemo- and Biocatalytic Approaches to Obtain Chiral Hydroxy Ketones and anti 1,3-Diols 248
Water soluble Ir-complexes for ECL signal amplification in pathogens detection 244
Self-assembled complex promotes cell proliferation and stem cell self-renewal through redox signaling in in vivo model 241
Fluorinated dichloride platinum complexes: a new series of promising anticancer agents against orphan tumors 240
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 236
VCD spectroscopy as an excellent probe of chiral metal complexes containing a carbon monoxide vibrational chromophore 236
Novel platinum agents and mesenchymal stromal cells for thoracic malignancies : state of the art and future perspectives 235
A tandem MS precursor-ion scan approsch to identify variable covalent modification of albumin Cys34 : a new tool for studyng vascular carbonylation 234
Exploring the copper binding ability of Mets7 hCtr‐1 protein domain and His7 derivative: An insight in Michael addition catalysis 234
Chiral 1,4-bis-diphosphine ligands from optically active (Z)-olefines 229
Electrochemiluminescent multinuclear metal complexes for diagnostics 226
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ 226
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction 223
Luminescent self-assemblies of Pt(II) complexes in vivo 221
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines 219
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction 218
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes 215
Anticancer platinum(II) complexes bearing N-heterocycle rings 212
Synthesis and crystallographic structure of nickel(0) carbonyl complex with Bitianp, an atropoisomeric diphosphine 210
Evaluation of chemical diversity of biotinylated chiral 1,3-diamines as a catalytic moiety in artificial imine reductase 208
Enhancing Pt (IV) Complexes Anticancer Activity Upon Encapsulation in Stimuli Responsive Nanocages 207
Malignant Pleural Mesothelioma : State of the art and advanced cell therapy 207
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 207
Chiral 1,4-diphosphines, 1,4-diphosphites and 1,4-diphosphonites from optically active (Z)-olefins as ligands for metal-catalyzed asymmetric hydrogenation and hydroformylation reactions 205
Analisi farmaceutica 202
Stereoselective synthesis of 1-methylcarbapenem precursors : studies on the diastereoselective hydroformylation of 4-vinyl b-lactam with aminophosphonite–phosphinite and aminophosphine–phosphite rhodium(I) complexes 201
Cationic platinum(II) complexes active in vivo as anticancer drugs 201
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex 196
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 194
Asymmetric reductions of ethyl 2-(benzamidomethyl)-3-oxobutanoate by yeasts 193
Asymmetric reduction by transition metals complexes and biocatalysts 193
Luminescent water-soluble cycloplatinated complexes: structural, photophysical, electrochemical and chiroptical properties 193
Asymmetric Hydrogenation of prochiral Ketones catalyzed by Ru(II)Cl2diphosphine/diamine system 192
3-(Hydroxy(phenyl)methyl)azetidin-2-ones obtained via catalytic asymmetric hydrogenation or by biotransformation 192
One-pot catalytic strategies for the efficient and enantioselective synthesis of L-Carnosine 190
Aminophosphonite-phosphite and aminophosphonite-phosphinite ligands with mixed chirality: preparation and catalytic applications in asymmetric hydrogenation and hydroformylation 190
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH) 190
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase 190
Catalytic Applications for Heavy Metals Bio-recovery 190
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH) 185
Anticancer platinum‑drug delivered by mesenchymal stromal cells improves its activity on glioblastoma 183
DIOPHEP, a chiral diastereoisomer bisphosphine ligands : synthesis and applications in asymmetric hydrogenations 179
On the relation between carbonyl stretching frequencies and the donor power of chelating diphosphines in nickel dicarbonyl complexes 178
Structural variations on chiral ligands : new chelating diphosphines from optically active (1,4)-(Z)-2-butenes 177
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 177
Mesenchymal stromal cells for antineoplastic drug loading and delivery 175
catalisi enantioselettiva : sintesi di istidina non naturale e istidina non naturale deuterata 173
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction 167
Cationic Pt(II) complex based on 8-aminoquinoline: in vitro activity against human glioblastoma 167
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre 166
difosfine chelanti innovative e loro applicazioni in catalisi asimmetrica. 165
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase‑B 165
New chiral ligands for the enantioselective catalysis with transition metal complexes 164
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction 162
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 161
Vibrational circular dichroism and chiroptical properties of chiral Ir(III) luminescent complexes 160
One-pot reactions in catalysis: a valuable tool for the synthesis of enantiopure intermediates for pharmaceutical applications 159
STAT3 direct inhibitors: from MD77 to AC33 159
Ni²⁺ and Cu²⁺ Biosorption by EPS-Producing Serratia plymuthica Strains and Potential Bio-Catalysis of the Organo–Metal Complexes 158
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands 157
Hystidine and deuterium labelled hystidine by catalytic reduction with Rh(I)-diphosphine complexes and non coordinating strong acids. 156
Amphiphilic Pt(II) complex for in vivo imaging applications 153
Hybrid Catalysts from Copper Biosorbing Bacterial Strains and Their Recycling for Catalytic Application in the Asymmetric Addition Reaction of B2(pin)2 on α,β-Unsaturated Chalcones 153
Chiral Aminophosphonite-phosphite and Aminophosphonite-phosphinite Ligands in Asymmetric Hydroformylation of Carbapenem Antibiotics Precursors. 152
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 152
New Mets7 motif metallopeptide catalysts for Cu(I)-catalyzed asymmetric Henry reaction 150
The mesenchymal stromal cells increased the activity on glioblastoma of a new delivered anticancer platinum-drug 150
Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam 149
Histidine and deuterium labelled histidine by asymmetric catalytic reduction with gaseous H-2 or D-2 : the role of strong non-coordinating acids 149
DIOPHEP, A CHIRAL DIASTEREOISOMERIC BISPHOSPHINE LIGAND: SYNTHESIS AND APPLICATIONS IN ASYMMETRIC HYDROGENATIONS 146
Mets7 motif peptides in coordinative Cu(I) complexes: application in asymmetric Henry reaction 146
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 145
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds 145
Histidine and deuterium-labelled histidine by asymmetric catalytic reduction and assignment of the absolute stereochemistry by neutron diffraction 142
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma 142
Alizarin as a selective carrier in cytotoxic Pt(II) complexes toward Triple Negative Breast Cancer (TNBC) 141
ZedPhos Ru(II)/Diamine complexes in asymmetric reduction of carbonyl groups. 140
Equilibri ionici 1. : acidi e basi 140
Production of optically pure molecules by asymmetric reductions with yeasts 139
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy 139
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 139
Recycling of copper contaminants from wastewater as new hybrid catalysts for the synthesis of valuable pharmaceutical intermediates 138
Asymmetric Hydrogenation vs Transfer Hydrogenation in the Reduction of Cyclic Imines 138
New sp3 diphosphine-based rhodium catalysts for the asymmetric conjugate addition of aryl boronic acids to 3-azaarylpropenones 134
Natural, unnatural and D2 labelled aminoacids by asymmetric hydrogenation 132
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 132
Totale 19.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021831 0 0 0 0 0 0 86 148 134 162 189 112
2021/20222.356 211 97 85 140 187 161 192 134 308 157 194 490
2022/20232.568 341 253 237 207 259 400 76 191 258 62 185 99
2023/20241.829 77 148 112 111 316 104 139 164 48 132 232 246
2024/20254.723 188 425 212 474 399 273 260 431 266 398 481 916
2025/20266.196 994 845 1.630 939 1.059 723 6 0 0 0 0 0
Totale 24.836